本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kronos Bio, Inc.

0.7790
-0.0210-2.62%
盘后0.77900.00000.00%16:00 EDT
成交量:29.50万
成交额:23.18万
市值:4,749.50万
市盈率:-0.54
高:0.8250
开:0.7800
低:0.7710
收:0.8000
数据加载中...

公司资料

公司名字:
Kronos Bio, Inc.
交易所:
NASDAQ
成立时间:
2017
员工人数:
10
公司地址:
1300 South El Camino Real,Suite 400,San Mateo,California,United States
邮编:
94402
电话:
传真:
- -
简介:
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发新的癌症疗法,旨在通过针对失调转录的精确药物策略来改变患者的预后。

董事

名称
职位
Arie Belldegrun
Chairman of the Board of Director
Norbert Bischofberger
Director, President and Chief Executive Officer
David Tanen
Director
Elena Ridloff
Director
Jakob Loven
Director
John C. Martin
Director
Joshua Kazam
Director
Otello Stampacchia
Director
Rebecka Belldegrun
Director

股东

名称
职位
Norbert Bischofberger
Director, President and Chief Executive Officer
Barbara Kosacz
Chief Operating Officer and General Counsel
Yasir Al Wakeel
Chief Financial Officer and Head of Corporate Development
Christopher Dinsmore
Chief Scientific Officer
Jorge DiMartino
Chief Medical Officer and Executive Vice President, Clinical Development